NEW YORK (GenomeWeb) – GeneNews reported today that its third quarter revenues fell 51 percent as the company is changing how it bills for its ColonSentry colorectal cancer blood test and other diagnostics.

For the three-month period ended Sept. 30, GeneNews' revenues fell to $54,290 from $111,103 in the year-ago quarter. In a statement, GeneNews Chairman and CEO James Howard-Tripp called the revenue results "disappointing and reflective of the changes we are currently making in our billing processes."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

May
22
Sponsored by
Thermo Fisher Scientific

In this webinar, the third in the “New Frontiers in Liquid Biopsy Research” series, Dr. Liya Xu of the University of Southern California Michelson Center for Convergent Biosciences will discuss her team’s work using liquid biopsy technology for breast cancer research.

Jun
05

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.